Try our beta test site

Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 27, 2017 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
ClinicalTrials.gov Identifier:
NCT01273155
First received: January 7, 2011
Last updated: March 8, 2017
Last verified: January 27, 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 4, 2018
  Estimated Primary Completion Date: January 8, 2018 (Final data collection date for primary outcome measure)